Millan MJ - Search Results

1

S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.

Millan MJ, Mannoury la Cour C, Chanrion B, Dupuis DS, Di Cara B, Audinot V, Cussac D, Newman-Tancredi A, Kamal M, Boutin JA, Jockers R, Marin P, Bockaert J, Muller O, Dekeyne A, Lavielle G. Millan MJ, et al. J Pharmacol Exp Ther. 2012 Mar;340(3):750-64. doi: 10.1124/jpet.111.187468. Epub 2011 Dec 16. J Pharmacol Exp Ther. 2012. PMID: 22178752

2

Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking.

Cussac D, Newman-Tancredi A, Duqueyroix D, Pasteau V, Millan MJ. Cussac D, et al. Among authors: millan mj. Mol Pharmacol. 2002 Sep;62(3):578-89. doi: 10.1124/mol.62.3.578. Mol Pharmacol. 2002. PMID: 12181434

3

Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.

Newman-Tancredi A, Cussac D, Marini L, Millan MJ. Newman-Tancredi A, et al. Among authors: millan mj. Mol Pharmacol. 2002 Sep;62(3):590-601. doi: 10.1124/mol.62.3.590. Mol Pharmacol. 2002. PMID: 12181435

4

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.

Millan MJ, Maiofiss L, Cussac D, Audinot V, Boutin JA, Newman-Tancredi A. Millan MJ, et al. J Pharmacol Exp Ther. 2002 Nov;303(2):791-804. doi: 10.1124/jpet.102.039867. J Pharmacol Exp Ther. 2002. PMID: 12388666

5

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor.

Newman-Tancredi A, Cussac D, Audinot V, Nicolas JP, De Ceuninck F, Boutin JA, Millan MJ. Newman-Tancredi A, et al. Among authors: millan mj. J Pharmacol Exp Ther. 2002 Nov;303(2):805-14. doi: 10.1124/jpet.102.039875. J Pharmacol Exp Ther. 2002. PMID: 12388667

6

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.

Newman-Tancredi A, Cussac D, Quentric Y, Touzard M, Verrièle L, Carpentier N, Millan MJ. Newman-Tancredi A, et al. Among authors: millan mj. J Pharmacol Exp Ther. 2002 Nov;303(2):815-22. doi: 10.1124/jpet.102.039883. J Pharmacol Exp Ther. 2002. PMID: 12388668

7

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.

Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL. Millan MJ, et al. J Pharmacol Exp Ther. 2004 Jun;309(3):903-20. doi: 10.1124/jpet.103.062398. Epub 2004 Feb 20. J Pharmacol Exp Ther. 2004. PMID: 14978194

8

S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.

Millan MJ, Brocco M, Papp M, Serres F, La Rochelle CD, Sharp T, Peglion JL, Dekeyne A. Millan MJ, et al. J Pharmacol Exp Ther. 2004 Jun;309(3):936-50. doi: 10.1124/jpet.103.062463. Epub 2004 Feb 20. J Pharmacol Exp Ther. 2004. PMID: 14978196 Free article.

9

The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.

Millan MJ, Gobert A, Roux S, Porsolt R, Meneses A, Carli M, Di Cara B, Jaffard R, Rivet JM, Lestage P, Mocaer E, Peglion JL, Dekeyne A. Millan MJ, et al. J Pharmacol Exp Ther. 2004 Oct;311(1):190-203. doi: 10.1124/jpet.104.069625. Epub 2004 May 14. J Pharmacol Exp Ther. 2004. PMID: 15146031

10

Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin.

Dekeyne A, Millan MJ. Dekeyne A, et al. Among authors: millan mj. Neuropharmacology. 2006 Sep;51(4):718-26. doi: 10.1016/j.neuropharm.2006.05.012. Epub 2006 Jun 30. Neuropharmacology. 2006. PMID: 16814817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

433 results

Search Page